4//SEC Filing
Lorianne Masuoka K. 4
Accession 0001181431-10-006211
CIK 0000906709other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 11:56 AM ET
Size
5.8 KB
Accession
0001181431-10-006211
Insider Transaction Report
Form 4
Lorianne Masuoka K.
SVP & Chief Medical Officer
Transactions
- Award
Stock Option
2010-02-01$11.34/sh+125,000$1,417,500→ 125,000 totalExercise: $11.34Exp: 2018-02-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The shares subject to this stock option shall vest on a monthly pro-rata basis over a period of four (4) years from the grant date (February 1, 2010).
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001466086
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 11:56 AM ET
- Size
- 5.8 KB